0001567619-23-005299.txt : 20230317 0001567619-23-005299.hdr.sgml : 20230317 20230317214715 ACCESSION NUMBER: 0001567619-23-005299 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230315 FILED AS OF DATE: 20230317 DATE AS OF CHANGE: 20230317 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Guyer Charles Greg CENTRAL INDEX KEY: 0001811096 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 23744785 MAIL ADDRESS: STREET 1: C/O BIOMARIN PHARMACEUTICAL INC. STREET 2: 770 LINDARO ST. CITY: SAN RAFAEL STATE: CA ZIP: 94901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc1.xml FORM 4 X0306 4 2023-03-15 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001811096 Guyer Charles Greg C/O BIOMARIN PHARMACEUTICAL INC. 770 LINDARO ST. SAN RAFAEL CA 94901 0 1 0 0 EVP, Chief Technical Officer Common Stock 2023-03-15 4 A 0 8900 0 A 51320 D Common Stock 2023-03-15 4 F 0 1856 87.74 D 49464 D Stock Option (Right to buy Common Stock) 87.74 2023-03-15 4 A 0 20320 0 A 2024-03-15 2033-03-14 Common Stock 20320 20320 D Restricted stock units granted on March 15, 2023. Price not applicable. Option grant vests 12/48th on March 15, 2024 and 1/48th on the 15th day of each month thereafter. /s/ Eric Fleekop, Attorney-in-Fact 2023-03-17